BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 3517784)

  • 1. [Expression of class II HLA antigens (HLA-DR, DQW1, DQW3) in normal skin and cutaneous pathology].
    Gomes M; Schmitt D; Dezutter-Dambuyant C; Capra JD; Thivolet J
    Pathol Biol (Paris); 1986 Mar; 34(3):157-64. PubMed ID: 3517784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface expression of invariant gamma-chain of class II histocompatibility antigens in human skin.
    Claesson-Welsh L; Scheynius A; Tjernlund U; Peterson PA
    J Immunol; 1986 Jan; 136(2):484-90. PubMed ID: 2416807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc gamma-receptors and HLA-DR antigens on endothelial cells in psoriatic skin lesions.
    Bjerke JR; Livden JK; Matre R
    Acta Derm Venereol; 1988; 68(4):306-11. PubMed ID: 2459875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant gamma-interferon on HLA-DR and DQ expression by skin cells in short-term organ culture.
    Messadi DV; Pober JS; Murphy GF
    Lab Invest; 1988 Jan; 58(1):61-7. PubMed ID: 3121914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II antigen expression in normal human epidermis.
    Carr MM; McVittie E; Guy K; Gawkrodger DJ; Hunter JA
    Immunology; 1986 Oct; 59(2):223-7. PubMed ID: 2429921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR-antigen bearing keratinocytes in various dermatologic disorders.
    Smolle J
    Acta Derm Venereol; 1985; 65(1):9-13. PubMed ID: 2578718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of HLA-DR expression by cells involved in the skin lesions of tuberculoid and lepromatous leprosy.
    Collings LA; Tidman N; Poulter LW
    Clin Exp Immunol; 1985 Jul; 61(1):58-66. PubMed ID: 3862470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
    López-Nevot MA; Garcia E; Romero C; Oliva MR; Serrano S; Garrido F
    Exp Clin Immunogenet; 1988; 5(4):203-12. PubMed ID: 3078572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatoses.
    Lampert IA
    Clin Exp Immunol; 1984 Jul; 57(1):93-100. PubMed ID: 6204802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
    Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
    Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of expression of class II major histocompatibility complex determinants on keratinocytes in bullous pemphigoid.
    Venning VA; Dean D; Wojnarowska F
    Br J Dermatol; 1992 May; 126(5):463-7. PubMed ID: 1610686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.
    Kwok WW; Kovats S; Thurtle P; Nepom GT
    J Immunol; 1993 Mar; 150(6):2263-72. PubMed ID: 8450211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural analysis of DR and DQ molecules among three HLA-D clusters associated with HLA-DR4].
    Ikeda H
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):898-907. PubMed ID: 2417927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II sublocus expression in benign and malignant breast epithelium.
    Zuk JA; Walker RA
    J Pathol; 1988 Aug; 155(4):301-9. PubMed ID: 2459333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HLA-DR, -DQ, and -DP antigens on renal tubular cells during rejection episodes.
    Russ GR; Pascoe V; d'Apice AJ; Seymour AE
    Transplant Proc; 1986 Apr; 18(2):293-7. PubMed ID: 3515666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.